{"rows":[{"id":5863,"title":"Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy","authors":"Brian Ross","journal":"Journal of Psychedelic Studies","publication_date":"2026-08-13","publication_year":2026,"doi":"10.1556/2054.2026.00517","pubmed_id":null,"openalex_id":"https://openalex.org/W7202362192","source_url":"https://doi.org/10.1556/2054.2026.00517","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Animal Study,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-15 01:20:13","last_checked":"2026-08-20 01:20:19","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00517","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2026.00517","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00517","source_url":"https://doi.org/10.1556/2054.2026.00517","doi":"10.1556/2054.2026.00517","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5830,"title":"Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens","authors":"Jenna Varley","journal":"Journal of Psychedelic Studies","publication_date":"2019-02-25","publication_year":2019,"doi":"10.1556/2054.2019.005","pubmed_id":null,"openalex_id":"https://openalex.org/W2915910581","source_url":"https://doi.org/10.1556/2054.2019.005","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:50","last_checked":"2026-08-09 08:25:50","bibtex":null,"source_record_id":"DOI:10.1556/2054.2019.005","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2019.005","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2019.005","source_url":"https://doi.org/10.1556/2054.2019.005","doi":"10.1556/2054.2019.005","pmid":"","publication_date":"2019-02-25","importer_version":"2.1.3","text_redistributed":false}},{"id":5813,"title":"The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review","authors":"Lennart Wiepking, Eduard J. de Bruin, Alexandra Ghiţă","journal":"Journal of Psychedelic Studies","publication_date":"2023-11-29","publication_year":2023,"doi":"10.1556/2054.2023.00244","pubmed_id":null,"openalex_id":"https://openalex.org/W4389139111","source_url":"https://doi.org/10.1556/2054.2023.00244","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Wellbeing,Mystical Experience,Review Article","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:33","last_checked":"2026-08-09 08:25:33","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00244","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00244","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00244","source_url":"https://doi.org/10.1556/2054.2023.00244","doi":"10.1556/2054.2023.00244","pmid":"","publication_date":"2023-11-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5717,"title":"Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview","authors":"Hörnqvist Nils","journal":"Journal of Psychedelic Studies","publication_date":"2026-07-13","publication_year":2026,"doi":"10.1556/2054.2026.00505","pubmed_id":null,"openalex_id":"https://openalex.org/W7168134125","source_url":"https://doi.org/10.1556/2054.2026.00505","substance_tags":"psilocybin","topic_tags":"Depression,Review Article,Observational Study,Treatment-Resistant Depression","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-07-14 01:20:09","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00505","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1556/2054.2026.00505","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1556/2054.2026.00505","source_url":"https://doi.org/10.1556/2054.2026.00505","doi":"10.1556/2054.2026.00505","pmid":"","publication_date":"2026-07-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5155,"title":"The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training","authors":"Elizabeth M. Nielson, Jeffrey Guss","journal":"Journal of Psychedelic Studies","publication_date":"2018-10-05","publication_year":2018,"doi":"10.1556/2054.2018.009","pubmed_id":null,"openalex_id":"https://openalex.org/W2895740693","source_url":"https://doi.org/10.1556/2054.2018.009","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Healthcare Workers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:01","last_checked":"2026-08-09 08:25:50","bibtex":null,"source_record_id":"DOI:10.1556/2054.2018.009","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2018.009","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2018.009","source_url":"https://doi.org/10.1556/2054.2018.009","doi":"10.1556/2054.2018.009","pmid":"","publication_date":"2018-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5124,"title":"Use of psilocybin (“mushrooms”) among US adults: 2015-2018","authors":"R. Andrew Yockey, Keith A. King","journal":"Journal of Psychedelic Studies","publication_date":"2021-02-04","publication_year":2021,"doi":"10.1556/2054.2020.00159","pubmed_id":null,"openalex_id":"https://openalex.org/W3126260393","source_url":"https://doi.org/10.1556/2054.2020.00159","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Aging,Observational Study","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:00","last_checked":"2026-08-09 08:25:47","bibtex":null,"source_record_id":"DOI:10.1556/2054.2020.00159","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2020.00159","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2020.00159","source_url":"https://doi.org/10.1556/2054.2020.00159","doi":"10.1556/2054.2020.00159","pmid":"","publication_date":"2021-02-04","importer_version":"2.1.3","text_redistributed":false}},{"id":5106,"title":"Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands","authors":"Anna Lutkajtis","journal":"Journal of Psychedelic Studies","publication_date":"2021-04-16","publication_year":2021,"doi":"10.1556/2054.2021.00162","pubmed_id":null,"openalex_id":"https://openalex.org/W3156510154","source_url":"https://doi.org/10.1556/2054.2021.00162","substance_tags":"psilocybin","topic_tags":"Mystical Experience","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1556/2054.2021.00162","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2021.00162","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2021.00162","source_url":"https://doi.org/10.1556/2054.2021.00162","doi":"10.1556/2054.2021.00162","pmid":"","publication_date":"2021-04-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5105,"title":"Have Norwegians tried psilocybin, and do they accept it as a medicine?","authors":"Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy, Tor Morten Kvam, Silje Endresen Rème","journal":"Journal of Psychedelic Studies","publication_date":"2021-04-16","publication_year":2021,"doi":"10.1556/2054.2021.00167","pubmed_id":null,"openalex_id":"https://openalex.org/W3152965122","source_url":"https://doi.org/10.1556/2054.2021.00167","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Observational Study,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1556/2054.2021.00167","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2021.00167","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2021.00167","source_url":"https://doi.org/10.1556/2054.2021.00167","doi":"10.1556/2054.2021.00167","pmid":"","publication_date":"2021-04-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5063,"title":"Is MDD the right target for early-stage psychedelic-assisted therapy trials?","authors":"Benjamin R. Lewis, Kevin Byrne","journal":"Journal of Psychedelic Studies","publication_date":"2021-09-15","publication_year":2021,"doi":"10.1556/2054.2021.00180","pubmed_id":null,"openalex_id":"https://openalex.org/W3199274122","source_url":"https://doi.org/10.1556/2054.2021.00180","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:45","bibtex":null,"source_record_id":"DOI:10.1556/2054.2021.00180","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2021.00180","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2021.00180","source_url":"https://doi.org/10.1556/2054.2021.00180","doi":"10.1556/2054.2021.00180","pmid":"","publication_date":"2021-09-15","importer_version":"2.1.3","text_redistributed":false}},{"id":4956,"title":"Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions","authors":"Annie M. McCartney, H. T. McGovern, Alexander De Foe","journal":"Journal of Psychedelic Studies","publication_date":"2022-06-09","publication_year":2022,"doi":"10.1556/2054.2022.00211","pubmed_id":null,"openalex_id":"https://openalex.org/W4282040347","source_url":"https://doi.org/10.1556/2054.2022.00211","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-08-09 08:25:41","bibtex":null,"source_record_id":"DOI:10.1556/2054.2022.00211","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2022.00211","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2022.00211","source_url":"https://doi.org/10.1556/2054.2022.00211","doi":"10.1556/2054.2022.00211","pmid":"","publication_date":"2022-06-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4898,"title":"Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum","authors":"Geoffrey M. Bove, David J. Mokler","journal":"Journal of Psychedelic Studies","publication_date":"2022-12-07","publication_year":2022,"doi":"10.1556/2054.2022.00230","pubmed_id":null,"openalex_id":"https://openalex.org/W4311816479","source_url":"https://doi.org/10.1556/2054.2022.00230","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study,Immune Function","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1556/2054.2022.00230","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2022.00230","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2022.00230","source_url":"https://doi.org/10.1556/2054.2022.00230","doi":"10.1556/2054.2022.00230","pmid":"","publication_date":"2022-12-07","importer_version":"2.1.3","text_redistributed":false}},{"id":4858,"title":"Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism","authors":"Benjamin A. Korman","journal":"Journal of Psychedelic Studies","publication_date":"2023-01-16","publication_year":2023,"doi":"10.1556/2054.2022.00240","pubmed_id":null,"openalex_id":"https://openalex.org/W4316511320","source_url":"https://doi.org/10.1556/2054.2022.00240","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1556/2054.2022.00240","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2022.00240","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2022.00240","source_url":"https://doi.org/10.1556/2054.2022.00240","doi":"10.1556/2054.2022.00240","pmid":"","publication_date":"2023-01-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4857,"title":"Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands","authors":"Anna Lutkajtis, Jules Evans","journal":"Journal of Psychedelic Studies","publication_date":"2023-01-16","publication_year":2023,"doi":"10.1556/2054.2022.00232","pubmed_id":null,"openalex_id":"https://openalex.org/W4316511384","source_url":"https://doi.org/10.1556/2054.2022.00232","substance_tags":"psilocybin","topic_tags":"Spirituality,Adverse Events","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1556/2054.2022.00232","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2022.00232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2022.00232","source_url":"https://doi.org/10.1556/2054.2022.00232","doi":"10.1556/2054.2022.00232","pmid":"","publication_date":"2023-01-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4855,"title":"Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial","authors":"Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck","journal":"Journal of Psychedelic Studies","publication_date":"2023-01-18","publication_year":2023,"doi":"10.1556/2054.2022.00222","pubmed_id":null,"openalex_id":"https://openalex.org/W4317355030","source_url":"https://doi.org/10.1556/2054.2022.00222","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1556/2054.2022.00222","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2022.00222","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2022.00222","source_url":"https://doi.org/10.1556/2054.2022.00222","doi":"10.1556/2054.2022.00222","pmid":"","publication_date":"2023-01-18","importer_version":"2.1.3","text_redistributed":false}},{"id":4829,"title":"View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy","authors":"Colin H. Simonds","journal":"Journal of Psychedelic Studies","publication_date":"2023-03-28","publication_year":2023,"doi":"10.1556/2054.2023.00255","pubmed_id":null,"openalex_id":"https://openalex.org/W4361204700","source_url":"https://doi.org/10.1556/2054.2023.00255","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:36","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00255","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00255","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00255","source_url":"https://doi.org/10.1556/2054.2023.00255","doi":"10.1556/2054.2023.00255","pmid":"","publication_date":"2023-03-28","importer_version":"2.1.3","text_redistributed":false}},{"id":4785,"title":"Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy","authors":"Benjamin M. Ross, James T. Neill","journal":"Journal of Psychedelic Studies","publication_date":"2023-08-21","publication_year":2023,"doi":"10.1556/2054.2023.00264","pubmed_id":null,"openalex_id":"https://openalex.org/W4386021261","source_url":"https://doi.org/10.1556/2054.2023.00264","substance_tags":"psilocybin","topic_tags":"Anxiety,Receptor Pharmacology,Personality Change,Observational Study,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:34","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00264","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00264","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00264","source_url":"https://doi.org/10.1556/2054.2023.00264","doi":"10.1556/2054.2023.00264","pmid":"","publication_date":"2023-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":4767,"title":"Self-perception and self-recognition while looking in the mirror on psilocybin","authors":"Sam Elias, Stephanie Spivak, Alexa Alverez, Alejandro Gili Olivares, Maria Ferrol, Julian Paul Keenan","journal":"Journal of Psychedelic Studies","publication_date":"2023-09-19","publication_year":2023,"doi":"10.1556/2054.2023.00251","pubmed_id":null,"openalex_id":"https://openalex.org/W4386864795","source_url":"https://doi.org/10.1556/2054.2023.00251","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:34","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00251","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00251","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00251","source_url":"https://doi.org/10.1556/2054.2023.00251","doi":"10.1556/2054.2023.00251","pmid":"","publication_date":"2023-09-19","importer_version":"2.1.3","text_redistributed":false}},{"id":4735,"title":"Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness","authors":"Danelle Jones","journal":"Journal of Psychedelic Studies","publication_date":"2023-11-16","publication_year":2023,"doi":"10.1556/2054.2023.00306","pubmed_id":null,"openalex_id":"https://openalex.org/W4388730617","source_url":"http://dx.doi.org/10.1556/2054.2023.00306","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:33","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00306","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.1556/2054.2023.00306","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00306","source_url":"http://dx.doi.org/10.1556/2054.2023.00306","doi":"10.1556/2054.2023.00306","pmid":"","publication_date":"2023-11-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4733,"title":"Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials","authors":"Tahlia R. Harrison","journal":"Journal of Psychedelic Studies","publication_date":"2023-11-20","publication_year":2023,"doi":"10.1556/2054.2023.00267","pubmed_id":null,"openalex_id":"https://openalex.org/W4388822593","source_url":"https://doi.org/10.1556/2054.2023.00267","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:33","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00267","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00267","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00267","source_url":"https://doi.org/10.1556/2054.2023.00267","doi":"10.1556/2054.2023.00267","pmid":"","publication_date":"2023-11-20","importer_version":"2.1.3","text_redistributed":false}},{"id":4672,"title":"Indigenous psilocybin mushroom practices: An annotated bibliography","authors":"Nicholas Spiers, Beatriz Caiuby Labate, Anna O. Ermakova, Patrick Farrell, Osiris Sinuhé González Romero, Ibrahim Gabriell, Nidia Olvera","journal":"Journal of Psychedelic Studies","publication_date":"2024-02-19","publication_year":2024,"doi":"10.1556/2054.2023.00297","pubmed_id":null,"openalex_id":"https://openalex.org/W4391924240","source_url":"https://doi.org/10.1556/2054.2023.00297","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:31","bibtex":null,"source_record_id":"DOI:10.1556/2054.2023.00297","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2023.00297","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2023.00297","source_url":"https://doi.org/10.1556/2054.2023.00297","doi":"10.1556/2054.2023.00297","pmid":"","publication_date":"2024-02-19","importer_version":"2.1.3","text_redistributed":false}}],"total":48,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of Psychedelic Studies","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}